BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32618256)

  • 21. Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.
    Nogareda F; Gunregjav N; Sarankhuu A; Munkhbat E; Ichinnorov E; Nymadawa P; Wannemuehler K; Mulders MN; Hagan J; Patel MK
    Vaccine; 2020 May; 38(26):4200-4208. PubMed ID: 32381479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of vaccine-preventable diseases.
    Witte JJ
    Postgrad Med; 1974 Oct; 56(4):55-9. PubMed ID: 4412686
    [No Abstract]   [Full Text] [Related]  

  • 23. Trend of measles-rubella vaccination coverage and impact on measles epidemiology in the Savannah Region, Ghana; 2018-2022: A secondary data analysis.
    Rockson Adjei M; Longsignikuu A; Saeed Iddris I; Nang Suuri T; Asamoah B; Okoye M; Vanessa Baafi J; Kubio C; Ohene SA; Grobusch MP
    Vaccine; 2024 Mar; 42(8):1910-1917. PubMed ID: 38365480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
    Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: nationwide population-based survey, 2010.
    Khetsuriani N; Zakikhany K; Jabirov S; Saparova N; Ursu P; Wannemuehler K; Wassilak S; Efstratiou A; Martin R
    Vaccine; 2013 Oct; 31(42):4917-22. PubMed ID: 23859842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.
    Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I
    J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia.
    Mutembo S; Carcelen A; Mwansa FD; Searle K; Wanyiri JW; Book C; Thuma PE; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2018 Dec; 99(6):1639-1642. PubMed ID: 30277204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017.
    Khetsuriani N; Zaika O; Slobodianyk L; Scobie HM; Cooley G; Dimitrova SD; Stewart B; Geleishvili M; Allahverdiyeva V; O'Connor P; Huseynov S
    Vaccine; 2022 Mar; 40(12):1810-1820. PubMed ID: 35153095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study.
    Kostik MM; Lubimova NA; Fridman IV; Goleva OV; Kharit SM
    Pediatr Rheumatol Online J; 2021 Jul; 19(1):108. PubMed ID: 34225748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. East African immigrant children in Australia have poor immunisation coverage.
    Paxton GA; Rice J; Davie G; Carapetis JR; Skull SA
    J Paediatr Child Health; 2011 Dec; 47(12):888-92. PubMed ID: 22171831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles and rubella immunity in the population of Bhutan, 2017.
    Wangchuk S; Nogareda F; Tshering N; Khandu L; Pelden S; Wannemuehler K; Wangdi S; Wangchuk U; Mulders M; Tamang T; Patel MK
    Vaccine; 2019 Oct; 37(43):6463-6469. PubMed ID: 31500970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine.
    Giammanco G; Li Volti S; Salemi I; Giammanco Bilancia G; Mauro L
    Eur J Epidemiol; 1993 Mar; 9(2):199-202. PubMed ID: 8519358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-specific immunological effects of selected routine childhood immunisations: systematic review.
    Kandasamy R; Voysey M; McQuaid F; de Nie K; Ryan R; Orr O; Uhlig U; Sande C; O'Connor D; Pollard AJ
    BMJ; 2016 Oct; 355():i5225. PubMed ID: 27737830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.